Abuse Potential Clinical Trial
Official title:
A Randomized, Double-blind, Active- and Placebo-controlled, 6-way Crossover Study to Evaluate the Abuse Potential of Orally Administered Gabapentin Enacarbil Immediate Release Capsules Taken Alone and in Combination With Oxycodone in Healthy, Nondependent, Recreational Opioid Users
The purpose of this study is to assess the abuse potential of gabapentin enacarbil immediate release capsules taken alone and in combination with oxycodone in healthy adult, non-dependent, recreational opioid users.
The primary purpose of this study is to evaluate the abuse potential of gabapentin enacarbil immediate-release (GE-IR), the active moiety in Horizant, taken alone and taken in combination with oxycodone, compared to that of oxycodone alone. This study is a randomized, double-blind, active- and placebo-controlled, 6-way crossover design, aimed to assess the abuse potential, safety, and pharmacokinetics (PK) of GE-IR doses when administered alone or in combination with an opioid active control (oxycodone), and compared to placebo and oxycodone intake alone, in healthy, nondependent, recreational opioid users. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06097676 -
An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users
|
Phase 4 | |
Terminated |
NCT03200080 -
A Study to Determine the Abuse Potential of Tozadenant Relative to D-Amphetamine and Placebo When Administered Orally in Healthy, Non-Dependent, Recreational Polydrug Users
|
Phase 1 | |
Completed |
NCT04570436 -
Evaluating the Abuse Potential of NEURONTIN® When Taken Orally in Healthy Non-drug Dependent Participants With Sedative Drug Abuse Experience
|
Phase 4 | |
Completed |
NCT05053126 -
Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users
|
Phase 4 | |
Completed |
NCT05106153 -
A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem
|
Phase 1 | |
Completed |
NCT05319756 -
Study Evaluating the Abuse Potential of NEURONTIN® in Healthy Non-drug Dependent, Recreational Opioid Users
|
Phase 4 |